KVUE · Kenvue Inc.
$19.57
-1.56% last session
End-of-day data · close of 2026-10-23
Market cap
$38B
Enterprise value
$45B
Trailing P/E
22.8
Forward P/E
15.8
Dividend yield
4.0%
Beta
0.45
Avg volume
23M
Employees
22K
Daily Change %
-1.56%
5 Days Change
5.13%
10 Days Change
11.94%
30 Days Change
12.51%
60 Days Change
3.54%
Month to Day Change
15.45%
Year to Day Change
20.71%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — KVUE
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-11
Latest call per bank · past 12 months
UBS
Neutral$19.00
-2.9% vs priceBarclays
Equal-Weight$19.00
-2.9% vs priceCitigroup
Neutral$19.00
-2.9% vs priceJefferies
Hold$18.00
-8.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | UBS | Maintains | Neutral | $20.00 → $19.00 |
| 2026-07-21 | Barclays | Maintains | Equal-Weight | $18.00 → $19.00 |
| 2026-07-16 | UBS | Maintains | Neutral | $18.00 → $20.00 |
| 2026-04-15 | Citigroup | Maintains | Neutral | $20.00 → $19.00 |
| 2026-04-14 | Barclays | Maintains | Equal-Weight | $19.00 → $18.00 |
| 2026-04-07 | UBS | Maintains | Neutral | $19.00 → $18.00 |
| 2026-03-06 | Barclays | Maintains | Equal-Weight | $18.00 → $19.00 |
| 2026-02-18 | Canaccord Genuity | Maintains | Hold | $17.00 → $18.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 68 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 7.2% above the 50-day MA ($18.25).
- bullish: Price vs 200-day MA: Trading 10.6% above the 200-day MA ($17.69).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.23) — short-term momentum is improving.
- bullish: 52-week range: Price is within 5% of the 52-week high ($19.88).
KVUE Price Chart
Loading chart for KVUE…
Fundamentals
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
More in Household & Personal Products
PG
Procter & Gamble Company (The)
$373B 18.1% YTD
UL
Unilever PLC
$143B 5.1% YTD
CL
Colgate-Palmolive Company
$75B 26.2% YTD
EL
Estee Lauder Companies, Inc. (T
$39B 3.9% YTD
KMB
Kimberly-Clark Corporation
$37B 15.6% YTD
CHD
Church & Dwight Company, Inc.
$25B 31.1% YTD
CLX
Clorox Company (The)
$10B -8.9% YTD
ELF
e.l.f. Beauty, Inc.
$7B 51.2% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.